CA Stock MarketDetailed Quotes

MDNA Medicenna Therapeutics Corp

Watchlist
  • 2.200
  • +0.150+7.32%
15min DelayMarket Closed Oct 4 16:00 ET
168.15MMarket Cap-5789P/E (TTM)

Medicenna Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-9.40%4.04M
14.54%18.67M
34.67%4M
-2.93%4.78M
33.23%5.44M
2.98%4.46M
-27.46%16.3M
-4.99%2.97M
0.49%4.92M
-50.43%4.08M
Selling and administrative expenses
-23.88%1.25M
12.51%7.87M
54.12%2.13M
-9.63%1.78M
34.07%2.3M
-14.23%1.65M
-9.40%6.99M
-28.25%1.38M
-0.30%1.97M
-12.13%1.72M
-General and administrative expense
-23.88%1.25M
12.51%7.87M
54.12%2.13M
-9.63%1.78M
34.07%2.3M
-14.23%1.65M
-9.40%6.99M
-28.25%1.38M
-0.30%1.97M
-12.13%1.72M
Research and development costs
-1.07%2.78M
16.08%10.8M
17.47%1.86M
1.56%2.99M
32.68%3.13M
16.63%2.81M
-36.78%9.3M
33.17%1.59M
1.31%2.95M
-62.32%2.36M
Depreciation amortization depletion
400.00%5K
0.00%5K
----
0.00%2K
-50.00%1K
--1K
-86.49%5K
-85.71%1K
-80.00%2K
-80.00%2K
-Depreciation and amortization
400.00%5K
0.00%5K
----
0.00%2K
-50.00%1K
--1K
-86.49%5K
-85.71%1K
-80.00%2K
-80.00%2K
Operating profit
9.40%-4.04M
-14.54%-18.67M
-34.67%-4M
2.93%-4.78M
-33.23%-5.44M
-2.98%-4.46M
27.46%-16.3M
4.99%-2.97M
-0.49%-4.92M
50.43%-4.08M
Net non-operating interest income (expenses)
-4.62%330K
31.07%1.2M
-40.31%228K
-17.06%282K
111.11%342K
1,053.33%346K
1,224.64%914K
4,144.44%382K
2,025.00%340K
671.43%162K
Non-operating interest income
-4.62%330K
31.07%1.2M
-40.31%228K
-17.06%282K
111.11%342K
1,053.33%346K
1,224.64%914K
4,144.44%382K
2,025.00%340K
671.43%162K
Other net income (expenses)
-94.16%73K
-249.60%-7.99M
-699.61%-10.13M
-114.01%-482K
-54.61%1.37M
762.76%1.25M
3,187.28%5.34M
-1,339.77%-1.27M
4,548.65%3.44M
8,791.18%3.02M
Gain on sale of security
-94.16%73K
-249.60%-7.99M
-699.61%-10.13M
-114.01%-482K
-54.61%1.37M
762.76%1.25M
3,187.28%5.34M
-1,339.77%-1.27M
4,548.65%3.44M
8,791.18%3.02M
Income before tax
-27.08%-3.64M
-153.44%-25.47M
-260.58%-13.9M
-336.20%-4.98M
-315.51%-3.72M
31.12%-2.86M
55.49%-10.05M
-20.27%-3.86M
76.26%-1.14M
89.04%-896K
Income tax
Earnings from equity interest net of tax
Net income
-27.08%-3.64M
-153.44%-25.47M
-260.58%-13.9M
-336.20%-4.98M
-315.51%-3.72M
31.12%-2.86M
55.49%-10.05M
-20.27%-3.86M
76.26%-1.14M
89.04%-896K
Net income continuous operations
-27.08%-3.64M
-153.44%-25.47M
-260.58%-13.9M
-336.20%-4.98M
-315.51%-3.72M
31.12%-2.86M
55.49%-10.05M
-20.27%-3.86M
76.26%-1.14M
89.04%-896K
Noncontrolling interests
Net income attributable to the company
-27.08%-3.64M
-153.44%-25.47M
-260.58%-13.9M
-336.20%-4.98M
-315.51%-3.72M
31.12%-2.86M
55.49%-10.05M
-20.27%-3.86M
76.26%-1.14M
89.04%-896K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-27.08%-3.64M
-153.44%-25.47M
-260.58%-13.9M
-336.20%-4.98M
-315.51%-3.72M
31.12%-2.86M
55.49%-10.05M
-20.27%-3.86M
76.26%-1.14M
89.04%-896K
Diluted earnings per share
-25.00%-0.05
-131.25%-0.37
-233.33%-0.2
-250.00%-0.07
-400.00%-0.05
42.86%-0.04
61.90%-0.16
0.00%-0.06
77.78%-0.02
93.33%-0.01
Basic earnings per share
-25.00%-0.05
-131.25%-0.37
-233.33%-0.2
-250.00%-0.07
-400.00%-0.05
42.86%-0.04
61.90%-0.16
0.00%-0.06
77.78%-0.02
93.33%-0.01
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -9.40%4.04M14.54%18.67M34.67%4M-2.93%4.78M33.23%5.44M2.98%4.46M-27.46%16.3M-4.99%2.97M0.49%4.92M-50.43%4.08M
Selling and administrative expenses -23.88%1.25M12.51%7.87M54.12%2.13M-9.63%1.78M34.07%2.3M-14.23%1.65M-9.40%6.99M-28.25%1.38M-0.30%1.97M-12.13%1.72M
-General and administrative expense -23.88%1.25M12.51%7.87M54.12%2.13M-9.63%1.78M34.07%2.3M-14.23%1.65M-9.40%6.99M-28.25%1.38M-0.30%1.97M-12.13%1.72M
Research and development costs -1.07%2.78M16.08%10.8M17.47%1.86M1.56%2.99M32.68%3.13M16.63%2.81M-36.78%9.3M33.17%1.59M1.31%2.95M-62.32%2.36M
Depreciation amortization depletion 400.00%5K0.00%5K----0.00%2K-50.00%1K--1K-86.49%5K-85.71%1K-80.00%2K-80.00%2K
-Depreciation and amortization 400.00%5K0.00%5K----0.00%2K-50.00%1K--1K-86.49%5K-85.71%1K-80.00%2K-80.00%2K
Operating profit 9.40%-4.04M-14.54%-18.67M-34.67%-4M2.93%-4.78M-33.23%-5.44M-2.98%-4.46M27.46%-16.3M4.99%-2.97M-0.49%-4.92M50.43%-4.08M
Net non-operating interest income (expenses) -4.62%330K31.07%1.2M-40.31%228K-17.06%282K111.11%342K1,053.33%346K1,224.64%914K4,144.44%382K2,025.00%340K671.43%162K
Non-operating interest income -4.62%330K31.07%1.2M-40.31%228K-17.06%282K111.11%342K1,053.33%346K1,224.64%914K4,144.44%382K2,025.00%340K671.43%162K
Other net income (expenses) -94.16%73K-249.60%-7.99M-699.61%-10.13M-114.01%-482K-54.61%1.37M762.76%1.25M3,187.28%5.34M-1,339.77%-1.27M4,548.65%3.44M8,791.18%3.02M
Gain on sale of security -94.16%73K-249.60%-7.99M-699.61%-10.13M-114.01%-482K-54.61%1.37M762.76%1.25M3,187.28%5.34M-1,339.77%-1.27M4,548.65%3.44M8,791.18%3.02M
Income before tax -27.08%-3.64M-153.44%-25.47M-260.58%-13.9M-336.20%-4.98M-315.51%-3.72M31.12%-2.86M55.49%-10.05M-20.27%-3.86M76.26%-1.14M89.04%-896K
Income tax
Earnings from equity interest net of tax
Net income -27.08%-3.64M-153.44%-25.47M-260.58%-13.9M-336.20%-4.98M-315.51%-3.72M31.12%-2.86M55.49%-10.05M-20.27%-3.86M76.26%-1.14M89.04%-896K
Net income continuous operations -27.08%-3.64M-153.44%-25.47M-260.58%-13.9M-336.20%-4.98M-315.51%-3.72M31.12%-2.86M55.49%-10.05M-20.27%-3.86M76.26%-1.14M89.04%-896K
Noncontrolling interests
Net income attributable to the company -27.08%-3.64M-153.44%-25.47M-260.58%-13.9M-336.20%-4.98M-315.51%-3.72M31.12%-2.86M55.49%-10.05M-20.27%-3.86M76.26%-1.14M89.04%-896K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -27.08%-3.64M-153.44%-25.47M-260.58%-13.9M-336.20%-4.98M-315.51%-3.72M31.12%-2.86M55.49%-10.05M-20.27%-3.86M76.26%-1.14M89.04%-896K
Diluted earnings per share -25.00%-0.05-131.25%-0.37-233.33%-0.2-250.00%-0.07-400.00%-0.0542.86%-0.0461.90%-0.160.00%-0.0677.78%-0.0293.33%-0.01
Basic earnings per share -25.00%-0.05-131.25%-0.37-233.33%-0.2-250.00%-0.07-400.00%-0.0542.86%-0.0461.90%-0.160.00%-0.0677.78%-0.0293.33%-0.01
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data